ABOUT THIS EVENT

Phathom Pharmaceuticals (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, visits the Nasdaq MarketSite in Times Square. Phathom will celebrate their three-year anniversary since being listed on the Nasdaq.

In honor of the occasion, Terrie Curran, President and Chief Executive Officer, rings the Closing Bell.